Chronic inflammatory demyelinating polyradiculoneuropathy: A prevalence study in south east England

Journal of Neurology Neurosurgery and Psychiatry

Volumn 66, Issue 5, 1999, Pages 677-680

  Lunn, M P T ^a   Manji, H ^b   Choudhary, P P ^c   Hughes, R A C ^a   Thomas, P K ^d  

^a GUY S HOSPITAL   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Chronic inflammatory demyelinating polyradiculoneuropathy; Morbidity; Prevalence

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN ANTIBODY; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEMYELINATING NEUROPATHY; EPIDEMIOLOGICAL DATA; EPIDEMIOLOGY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; INFLAMMATORY DISEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; UNITED KINGDOM; WALKING AID;

EID: 0032918169     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.66.5.677     Document Type: Article

References (17)

1. Austin JH. Recurrent polyneuropathies and their corticosteroid treatment. Brain 1958;81:157-92.
2. Dyck PJ, O'Brien PC, Oviatt KF, et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982;11:136-41.
3. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-18.
4. Franssen H, Vermeulen M, Jennekens FGI. Chronic inflammatory neuropathies. In: Emery AEH, ed. Diagnostic criteria for neuromuscular disorders. London: Royal Society of Medicine Press, 1997.
5. Bromberg MB, Feldman EL, Albers JW. Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy. Neurology 1992;42:1157-63.
6. McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain 1987;110: 1617-30.
7. Gibbets E, Giebisch U. Natural course of acute and chronic monophasic inflammatory demyelinating polyneuropathies (IDP). A retrospective analysis of 266 cases. Acta Neurol Scand 1992;85:282-91.
8. Gorson KC, Allam G, Ropper AH. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 1997;48: 321-8.
9. Kusumi M, Nakashima K, Nakayama H, et al. Epidemiology of inflammatory neurological and inflammatory neuromuscular diseases in Tottori Prefecture, Japan. Psychiatry Clin Neurosci 1995;49:169-74.
10. Mohamed A, Pollard J, Walsh JC, et al. Prevalence of CIDP in NSW. J Clin Neurosci 1997;4:403.
11. van Swieten JC, Koudstaal MD, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-7.
12. Grand'Maison F, Feasby TE, Hahn AF, et al. Recurrent Guillain-Barre syndrome. Clinical and laboratory features. Brain 1992;115:1093-106.
13. Barohn RJ, Kissel JT, Warmolts JR, et al. Chronic inflammatory demyelinating polyradiculopathy: clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989;46:878-84.
14. Bleasel AF, Hawke SHB, Pollard JD, et al. IgG monoclonal paraproteinaemia and peripheral neuropathy. J Neurol Neurosurg Psychiatry 1993;56:52-7.
15. Biessels GJ, Franssen H, Van den Berg LH, et al. Multifocal motor neuropathy. J Neurol 1997;244:143-52.
16. Chaudhry V. Multifocal motor neuropathy. Semin Neurol 1998;18:73-81.
17. Parry GJ. AAEM case report No 30: multifocal motor neuropathy. Muscle Nerve 1996;19:269-76.